AQST Insider Trading Activity and SEC Form 4 Filings
AQST insider trading summary
Over the past 12 months, insiders at Aquestive Therapeutics, Inc. (AQST) reported 14 sales worth $2.3M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.3M.
Latest AQST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Daniel Barber | President and CEO | Sell | $106K (25,000 @ $4.22) |
| Sep 15, 2026 | Daniel Barber | President and CEO | Sell | $120K (25,000 @ $4.82) |
| Sep 9, 2026 | Sherry Korczynski | Chief Commercial Officer | Sell | $46K (8,750 @ $5.22) |
| Jul 16, 2026 | Daniel Barber | President and CEO | Sell | $82K (20,369 @ $4.00) |
| Jul 15, 2026 | Daniel Barber | President and CEO | Sell | $19K (4,631 @ $4.03) |
| Jun 23, 2026 | Julie Krop | Insider | Sell | $125K (25,000 @ $5.02) |
| Jun 15, 2026 | Daniel Barber | President and CEO | Sell | $104K (25,000 @ $4.16) |
| Mar 10, 2026 | A Ernest Toth Jr | Chief Financial Officer | Sell | $243K (58,254 @ $4.17) |
| Mar 10, 2026 | Lori J Braender | Chief Legal Officer | Sell | $167K (40,102 @ $4.17) |
| Mar 10, 2026 | Sherry Korczynski | Chief Commercial Officer | Sell | $66K (15,741 @ $4.17) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.